Florida Bans Cancer-Linked Firefighting Foam: What the New PFAS Law Means for Your Legal Rights
You may have spent years standing inside a cloud of white foam at the fire-training academy, never told that the foam was loaded with chemicals designed never to break down — chemicals that would stay in your blood for years, silently raising your risk of kidney cancer, testicular cancer, thyroid disease, and more. Or you may have spent decades drinking tap water a mile from a military base or an airport, never knowing that the foam they sprayed on training fires for decades had seeped into the aquifer beneath your kitchen. Florida’s new law banning cancer-linked firefighting foam and ordering water testing for PFAS contamination is the state finally catching up to what the science has shown for years — and what the manufacturers of that foam have been accused of knowing for far longer. We are Attorney911 — The Manginello Law Firm, PLLC. We handle toxic tort cases and the catastrophic-injury and wrongful-death claims that flow from them. This page is for the firefighter who was never warned, the family whose water was never tested, and the cancer patient wondering whether the foam they trained with for decades is the reason they are sitting in an oncology waiting room right now. What follows is everything we know about how these cases are built, what the law allows, what the evidence looks like, and what your rights are — in plain language, from the trial team that would handle a case like yours.
What the New Florida PFAS Law Requires
Florida’s new legislation does two things at the state level that the federal government has been moving toward for the past several years: it bans firefighting foam containing PFAS (per- and polyfluoroalkyl substances), and it requires water testing for PFAS contamination. The ban targets AFFF — aqueous film-forming foam — the product that was used for decades at military installations, commercial airports, fire-training academies, refineries, chemical plants, and industrial facilities across Florida and the entire country. AFFF was designed to smother flammable-liquid fires, particularly jet-fuel fires, and it did that job effectively. The problem is that the chemicals that made it work — PFOA, PFOS, and related compounds — are part of a family called “forever chemicals” because they do not break down in the environment or in the human body. They accumulate. They persist. And the science connecting them to cancer and other serious diseases has been building for years.
The water-testing mandate is, in some ways, the more consequential provision for community exposure. Florida’s hydrogeology makes the state uniquely vulnerable to groundwater contamination from PFAS. The state sits on a porous karst limestone substrate with a shallow aquifer system — meaning contaminants that hit the ground at a fire-training area or a military base can migrate rapidly into the drinking-water wells that serve municipal systems and private homes. Florida’s year-round warm climate and extensive outdoor fire-training protocols also mean that more AFFF was deployed, more days of the year, than in colder-climate states — increasing both the volume of foam used and the duration of firefighter dermal and inhalation exposure.
The federal regulatory backdrop is equally significant. In April 2024, the EPA finalized National Primary Drinking Water Regulations setting enforceable maximum contaminant levels for PFOA and PFOS at 4.0 parts per trillion each — a number so small it is essentially a declaration that there is no comfortable amount of these chemicals in drinking water. The EPA set the health-based Maximum Contaminant Level Goals for both at zero, meaning the agency found no safe threshold.
“EPA is finalizing… individual MCLs for PFOA and PFOS at 4.0 nanograms per liter (ng/L) or parts per trillion… and is finalizing health-based Maximum Contaminant Level Goals (MCLGs) for PFOA and PFOS at zero.”
In May 2024, the EPA designated PFOA and PFOS as CERCLA hazardous substances, opening potential contribution and cost-recovery pathways under the Superfund law and triggering a one-pound reportable quantity for releases. The Department of Defense has been phasing out AFFF in training and transitioning to fluorine-free foam alternatives under section 322 of the FY2020 National Defense Authorization Act. Florida’s new legislation adds a state-level enforcement and disclosure layer on top of these federal standards — requiring testing that may generate data proving contamination the federal timeline has not yet captured.
PFAS and Cancer: The Scientific Link
The science connecting PFAS to human disease is not speculative. It is built on years of epidemiological study, including the C8 Science Panel — an independent panel of epidemiologists established as part of a class-action settlement involving a DuPont plant in West Virginia — which found a “probable link” between PFOA exposure and six specific health conditions: kidney cancer, testicular cancer, high cholesterol, thyroid disease, pregnancy-induced hypertension, and ulcerative colitis. The C8 Science Panel’s findings are the foundation of much of the PFAS personal-injury litigation, and they have been corroborated by subsequent research.
The International Agency for Research on Cancer — the world’s leading cancer-science authority, part of the World Health Organization — classified PFOA as Group 1, carcinogenic to humans, in its Volume 135 monograph published in 2024. PFOS was classified as Group 2B, possibly carcinogenic to humans. The Group 1 designation for PFOA means the science has reached the point where the world’s top cancer authority considers the evidence sufficient to say this chemical causes cancer in people — not in animals, not in theory, in people.
The mechanism is biological persistence. PFAS compounds bind to serum proteins and concentrate in the liver and kidney. They are not metabolized. They have long human half-lives — PFOA persists in human blood serum for approximately two to four years, and PFOS for approximately three to five years. Every exposure adds to the body burden. A firefighter who trained with AFFF for twenty years, or a resident who drank contaminated water for a decade, has been accumulating these chemicals the entire time — and the diseases they cause can take years or decades to appear after the exposure begins.
This latency is both the medical reality and the legal challenge. Kidney cancer, testicular cancer, and thyroid disease may not be diagnosed until years — sometimes many years — after the exposure that caused them. The cancer patient sitting in an oncologist’s office today may be carrying the biological signature of foam they sprayed at a training burn fifteen years ago. The connection is real, but proving it requires specific expertise: a toxicologist board-certified in environmental medicine to establish general causation (that PFAS can cause this type of cancer), an exposure reconstruction specialist to estimate the dose from usage records and biomonitoring, and an oncologist to connect the specific diagnosis to the specific exposure.
Who Is at Risk: Firefighters, Military Personnel, Airport Workers, and Nearby Residents
PFAS exposure through AFFF falls into two broad pathways — occupational and community — and each creates a different evidentiary profile and a different damages tier.
Occupational exposure (firefighters, military personnel, airport crash-rescue crews): Firefighters who used AFFF in training or emergency response absorbed PFAS through two routes: dermal contact with the foam itself and inhalation of aerosolized particles during spray operations. The year-round Florida training climate meant more days on the pad, more foam on the skin, more chemical in the lungs. Military personnel at installations that conducted fire-training exercises with AFFF — particularly Navy, Air Force, and Space Force personnel assigned to crash-rescue and damage-control roles — faced the same dual-pathway exposure. Airport crash-rescue crews, who are required by federal regulation to maintain AFFF capability for fuel-fire suppression, were similarly exposed. The occupational exposure pathway tends to produce higher internal doses than community exposure, because the contact is direct, repeated, and concentrated.
Community exposure (residents near military bases, airports, and industrial facilities): PFAS from AFFF application sites leached into groundwater and contaminated municipal and private drinking-water supplies. Residents who consumed contaminated water — sometimes for years or decades without knowing it — ingested PFAS daily. The community pathway is insidious because the exposure is invisible: the water looks, smells, and tastes normal, and until testing is done, no one knows it contains chemicals at concentrations above the EPA’s 4.0 ppt limit. Florida’s karst geology made this pathway particularly dangerous — contaminants migrate fast through porous limestone into shallow aquifers that feed drinking-water wells.
Both pathways produce compensable injuries, but they require different proof. The firefighter case is built on employment records, training-burn logs, PPE issuance documentation, and blood serum testing. The community case is built on residence history, water-utility testing data, well-water sampling results, and the same blood serum biomonitoring. In both, the blood test is critical — it quantifies the internal dose and distinguishes the exposed plaintiff from background population levels.
Florida’s Military Bases and PFAS Contamination
Florida’s military installations have historically been among the most intensive users of AFFF in the country, and the documented contamination plumes associated with them are the foundation of many community exposure claims. Major installations where AFFF use has generated documented PFAS contamination include:
Naval Air Station Jacksonville — one of the largest Navy installations in the country, with decades of crash-rescue training and AFFF use generating groundwater contamination that has been the subject of federal environmental investigation.
MacDill Air Force Base — located in Tampa, with a long history of fire-training operations using AFFF and documented PFAS migration into surrounding groundwater.
Eglin Air Force Base — the massive installation in the Florida panhandle, home to extensive training operations including airfield fire-rescue exercises that used AFFF over decades.
Patrick Space Force Base — on Florida’s east coast near Cocoa Beach, with AFFF use in launch-operations and airfield fire-rescue training contributing to groundwater contamination that has reached surrounding communities.
These installations are not unique — AFFF was used at military bases across the country, and the DOD has begun documenting PFAS contamination at hundreds of facilities nationwide. But Florida’s combination of intensive AFFF use, porous geology, shallow drinking-water aquifers, and dense civilian populations adjacent to military installations creates an exposure landscape that is particularly severe. The state’s new water-testing mandate may produce data that documents contamination the federal timeline has not yet captured — and that data becomes discoverable evidence in private litigation.
The Companies Behind the Foam: Who Profited and What They Knew
The defendants in AFFF/PFAS litigation are not abstract entities — they are some of the largest chemical manufacturers in the world, and the evidence of what they knew, and when they knew it, is the engine of the punitive-damages theory in these cases.
3M Company was the primary manufacturer of PFAS-containing AFFF and the original developer of the PFOS chemistry that made the foam effective. 3M has already agreed to pay between approximately $10.3 billion (pre-tax present value) and up to $12.5 billion (nominal cap) over thirteen years to U.S. public water systems for PFAS remediation — a settlement announced in June 2023 and receiving final court approval in 2024. That settlement resolves municipal water-provider contamination claims. It does not compensate individuals who drank contaminated water and developed cancer. It does not compensate firefighters who absorbed PFAS through their skin and lungs. The personal-injury cases are a separate fight.
DuPont, Chemours, and Corteva — the corporate family that inherited the legacy PFAS liability from DuPont’s chemical operations — agreed to pay approximately $1.185 billion to public water providers in a separate settlement, also announced in June 2023. Chemours was spun off from DuPont in 2015, and that spinoff is itself part of the story — a corporate restructuring that moved legacy PFAS liability into a separate entity. These water-provider settlements contain no admission of liability. They are cleanup money for utilities, not compensation for sick people.
Tyco Fire Products, Kidde-Fenwal, National Foam, Chemguard, and other AFFF manufacturers and distributors face claims for designing, manufacturing, and selling a product containing bioaccumulative, persistent chemicals linked to cancer — with alleged knowledge of the health risks that, according to public-record evidence, major producers conducted internal toxicological studies decades before warning regulators or end users.
All of these defendants are part of the active multidistrict litigation consolidated in the U.S. District Court for the District of South Carolina — MDL No. 2873, In re: Aqueous Film-Forming Foams Products Liability Litigation, before Judge Richard M. Gergel. As of mid-2026, more than 15,000 actions were pending in that MDL. The first personal-injury bellwether trial was selected to focus on kidney cancer but was postponed after the court identified a large backlog of unfiled cases. The MDL handles shared discovery and pretrial proceedings, but each plaintiff retains an individual case — joining the MDL does not merge your claim into one big pot.
Legal Claims for PFAS Exposure: Products Liability, Toxic Tort, Medical Monitoring
The legal theories in AFFF/PFAS cases are built on multiple overlapping frameworks, each reaching a different aspect of the harm.
Products liability — design defect and failure to warn. The core theory against the manufacturers is that they designed and sold a product containing bioaccumulative, persistent chemicals linked to cancer, when safer alternatives existed, and that they knew or should have known of the health risks for decades before warning the end users — the firefighters, the military personnel, the airport crews — who were handling and spraying the foam. The failure-to-warn theory is particularly powerful because the manufacturer’s own internal toxicological research, much of which has been produced in the MDL discovery, is evidence that the danger was studied and documented long before any warning reached the people exposed.
Toxic tort — groundwater contamination and exposure pathway. PFAS from AFFF application sites leached into groundwater, contaminated drinking-water supplies, and created an ingestion exposure pathway for community residents. Plaintiffs who consumed contaminated water over a period of years may pursue exposure-based injury claims against the manufacturers whose product generated the contamination and against the facility owners whose use of AFFF caused the release.
Negligence per se — violation of environmental and public health standards. Florida’s new law, alongside the EPA’s PFAS drinking-water standards and the CERCLA hazardous-substance designations for PFOA and PFOS, may provide statutory standards whose violation supports negligence per se theories against facilities that failed to contain, remediate, or warn of PFAS contamination. The EPA’s 4.0 ppt maximum contaminant level for PFOA and PFOS in drinking water is now an enforceable federal standard — water that tests above that limit is over a federal health limit, and the entities responsible for the contamination that caused the exceedance may be answerable for the consequences.
Premises liability — failure to warn of toxic condition. Property owners where AFFF was used in training or emergency response — military bases, airports, fire-training academies, refineries, chemical plants — may owe a duty to invitees (firefighters, personnel, nearby residents) to warn of and remediate known toxic contamination on their premises. A facility that knew its groundwater was contaminated with PFAS and said nothing to the surrounding community may face premises-liability claims.
Medical monitoring — a compensable claim even without a cancer diagnosis. This is one of the most important and most misunderstood aspects of PFAS litigation. Plaintiffs with elevated blood-PFAS levels but no current cancer diagnosis may still recover the cost of medical surveillance — serial blood testing, imaging, cancer-screening protocols — as a substantial economic-damages category. The medical-monitoring cause of action recognizes that a person with a documented internal dose of a known carcinogen has a real, quantifiable, ongoing medical need: surveillance to catch the disease early if it develops. This is not a consolation prize. It is a recognized injury with a real cost structure, and it may be worth $50,000 to $150,000 or more depending on the surveillance protocol required.
Florida Law: Your Rights, the Deadline, and the Damages Available
Florida’s legal framework provides several advantages for PFAS exposure plaintiffs, and understanding them is the foundation of any case evaluation.
Statute of limitations. Florida’s statute of limitations for personal injury is generally four years — but in toxic tort cases involving latent diseases like cancer, the clock does not start on the date of exposure. It starts on the date of discovery: when the plaintiff discovered, or by reasonable diligence should have discovered, both the injury and its causal relationship to the exposure. This discovery rule is critical in PFAS cases because the cancer may not be diagnosed until decades after the foam was sprayed or the contaminated water was consumed. A firefighter who used AFFF in the 1990s and received a kidney cancer diagnosis in 2024 may have four years from the date they learned — or should have learned — that the PFAS exposure caused the cancer. This is not a green light to wait. The discovery rule is generous, but it is not infinite, and some states impose an outer deadline (a statute of repose) that can cut off a claim even before discovery. Anyone who suspects a connection between their diagnosis and PFAS exposure should confirm the current Florida limitations period and discovery-rule application with an attorney immediately.
Comparative negligence. Florida applies a pure comparative negligence standard. In toxic tort cases, this is rarely a significant deflator because exposure victims typically had no awareness of or control over the hazard — the firefighter was never told the foam was dangerous, the resident was never told the water was contaminated. The manufacturer cannot argue the plaintiff “should have known” about a risk the manufacturer itself was concealing.
Damages — no cap on compensatory damages for non-governmental defendants. Florida has no statutory cap on compensatory damages in personal injury or wrongful death cases involving non-governmental defendants. The state’s tort reform measures have imposed certain restrictions on noneconomic damages in medical malpractice contexts, but those restrictions do not apply to toxic tort cases against chemical manufacturers. Economic damages (medical costs, lost wages, future care) and noneconomic damages (pain and suffering, loss of quality of life, emotional distress) are both fully recoverable.
Punitive damages. Florida allows punitive damages under a clear-and-conving-evidence standard for intentional misconduct or gross negligence, and the state requires a bifurcated proceeding on punitives — meaning the jury first decides compensatory damages, and then a separate proceeding addresses punishment. In PFAS cases, punitive damages are a live theory given the public-record evidence that major producers conducted internal toxicological studies of PFAS bioaccumulation and health risks decades before warning regulators or end users. A company that studied the danger, confirmed it internally, and sold the product anyway — without warning the people who would absorb it — is the textbook predicate for punitive damages.
Wrongful death and survival claims. Florida allows survival claims (for medical expenses, lost wages, and pain and suffering accrued before death) and wrongful death claims (for the family’s losses — lost support, lost companionship, loss of guidance). If PFAS exposure caused or contributed to a cancer death, both tracks may be available. For families who have lost someone to kidney cancer, testicular cancer, or another PFAS-associated disease, the wrongful death claim is a separate cause of action with its own damages structure — and it is one we handle.
What Your Case May Be Worth
Case value in PFAS/AFFF litigation depends on three variables: the diagnosis, the exposure pathway, and the defendant identification. No two cases are identical, and the figures below are the landscape — not a promise about your case.
Medical monitoring only (elevated blood-PFAS, no diagnosed disease): approximately $50,000 to $150,000. This covers the cost of serial blood testing, imaging, cancer surveillance protocols, and the psychological burden of living with elevated cancer risk. It is a real, compensable economic-damages category.
Diagnosed PFAS-associated cancer with a clear exposure pathway: approximately $2,000,000 to $10,000,000 or more. Kidney cancer and testicular cancer command premium value because they carry the strongest epidemiological association with PFAS exposure — the C8 Science Panel found a “probable link” for both, and IARC classified PFOA as Group 1. A firefighter with twenty years of AFFF exposure and a kidney cancer diagnosis has a case that sits at the high end of this range or above. A community resident with documented water contamination and the same diagnosis may sit in a similar range, depending on the strength of the exposure reconstruction.
Wrongful death claims — where PFAS-associated cancer caused or contributed to a death — may exceed these ranges, particularly for younger decedents with significant lost-earnings projections. A firefighter who died at 45 of kidney cancer after a career of AFFF exposure leaves behind decades of lost wages, lost household services, and the full human loss that no spreadsheet can capture.
These ranges reflect the broader AFFF/PFAS mass tort landscape. Individual case values depend on diagnosis specificity, exposure-pathway clarity (direct firefighter dermal/inhalation exposure versus secondary groundwater ingestion), defendant identifiability, and jurisdiction. Mass tort settlements in the AFFF MDL have involved multi-billion-dollar global resolutions with major manufacturers for water-provider claims; individual plaintiff allocations within any personal-injury settlement structure will vary widely based on injury tier. Past results depend on the facts of each case and do not guarantee future outcomes.
The Evidence Clock: What Records Exist and How Fast They Disappear
PFAS cases are built on paper — and the paper is disappearing. Every category of evidence that proves exposure, dose, and causation is on a clock, and some of the clocks are already running out.
AFFF procurement, storage, and usage records at specific facilities. These records — purchase orders, delivery receipts, training-burn logs, spill reports, environmental site assessments — establish the volume, duration, and locations of PFAS-containing foam deployment. They are the foundation of exposure-pathway proof. Federal facilities (military installations) have begun document collection under NDAA mandates, but private facilities — airports, fire-training academies, industrial plants — may purge procurement records on standard business cycles. A fire-training academy that used AFFF for twenty years may have retention policies that allow destruction of purchase records after seven years. Once those records are gone, reconstructing what was used, when, and how much becomes forensic archaeology.
Blood serum PFAS testing results. This is the single most important piece of individual evidence in a PFAS case. A blood test measures the concentration of PFAS compounds in serum — quantifying the internal dose and distinguishing the exposed plaintiff from background population levels. Everyone has some PFAS in their blood — these chemicals are ubiquitous in the modern environment — but a firefighter who trained with AFFF for decades, or a resident who drank contaminated well water for years, will typically show levels far above background. The clock on this evidence is biological: PFOA has a serum half-life of approximately two to four years, and PFOS approximately three to five years. The levels decline over time after exposure ends — so the test should be done promptly to capture peak levels before further elimination dilutes the signal. The test also documents the temporal relationship to exposure, which is critical for specific causation.
Groundwater monitoring well data and drinking water sampling results. For community plaintiffs, water-testing data is the proof of the ingestion exposure pathway. Florida’s new testing mandate may generate state-collected data that becomes discoverable — but historical baseline sampling, if it exists, may be lost if not preserved through FOIA requests or discovery demands promptly. State-mandated testing will produce new data going forward, but the historical record — what was in the water ten or twenty years ago — may only exist in utility records, state environmental agency files, or DOD environmental reports that have their own retention schedules.
Manufacturer internal corporate documents. The evidence that manufacturers knew of PFAS bioaccumulation and health risks before warning end users — toxicological studies, internal communications, marketing materials, warning-label decisions — is the punitive-damages engine. Much of this has been produced in the AFFF MDL discovery, but facility-specific manufacturer correspondence and distributor warning documents must be sought before destruction or document-retention purges. This evidence is, in many cases, already in the public record through MDL proceedings — but connecting it to a specific facility’s procurement chain requires targeted discovery.
Firefighter employment and training records, PPE issuance logs, and incident response records. For occupational plaintiffs, these documents establish the duration, frequency, and intensity of direct AFFF exposure. Fire department and municipal records are subject to state records-retention schedules. Personnel records may be destroyed after statutory periods. The employment record that shows a firefighter was assigned to the crash-rescue unit at a specific airport for fifteen years, and was issued AFFF training gear annually, is the backbone of the occupational exposure case — and it may not survive indefinitely.
The preservation letter is the first thing that goes out. The day you call is the day we begin freezing evidence — notifying facilities, employers, water utilities, and manufacturers that records relevant to your claim must be preserved and that destruction will be treated as spoliation. In every toxic tort case we handle, the workplace accident and toxic exposure evidence is the most time-sensitive category, because the records that prove what you were exposed to, and how much, and for how long, are the records no one is required to keep forever.
The Insurance Company Playbook: What to Expect
The defense in PFAS cases is not a friendly adjuster calling to “check on you.” It is a sophisticated corporate defense apparatus, staffed by lawyers who have been defending chemical-exposure cases for decades. Here are the plays you should expect — and the counter to each.
Play 1: “Everyone has PFAS in their blood — you can’t prove our product caused your cancer.” This is the defense’s strongest card, and it is based on a real fact: PFAS is ubiquitous in the modern environment. It is in food packaging, stain-resistant carpets, nonstick cookware, and countless consumer products. The defense will argue that your PFAS levels came from background environmental exposure, not from their specific foam. The counter is biomonitoring combined with exposure reconstruction: a firefighter who trained with AFFF for twenty years will show serum levels far above background, and the exposure reconstruction specialist can estimate the dose from usage records, training frequency, and the specific foam formulations used at that facility. The gap between background levels and the plaintiff’s levels is the case.
Play 2: “Your cancer has many possible causes — you can’t prove PFAS caused this specific tumor.” Kidney cancer, testicular cancer, and thyroid disease all have multiple risk factors. The defense will argue that your cancer was idiopathic — meaning it came from nowhere — or that it was caused by smoking, diet, genetics, or some other exposure. The counter is the dose-response literature, the C8 Science Panel’s “probable link” findings, the IARC Group 1 classification for PFOA, and the treating oncologist’s testimony tying the specific diagnosis to the documented exposure. Causation in toxic tort is not about certainty — it is about probability, and the standard is a reasonable degree of medical certainty, not absolute proof.
Play 3: “You waited too long — the statute of limitations has run.” The defense will argue that the clock started ticking on the date of exposure, not the date of diagnosis, and that decades-old exposure falls outside the limitations period. The counter is the discovery rule: in Florida, the clock starts when you discovered, or should have discovered, both the injury and its causal connection to the exposure. A cancer diagnosis you received last year, combined with information about PFAS health risks that you only learned about recently, may be well within the four-year window — but this is a state-specific question that must be confirmed with an attorney, and some states impose an outer deadline (a statute of repose) that the discovery rule cannot defeat.
Play 4: The quick settlement offer. In some cases, particularly medical-monitoring-only claims, the defense may move quickly with a low offer designed to close the file before the plaintiff understands the full value of the case. A medical monitoring claim that will cost $100,000 in surveillance over a lifetime may be offered $15,000 to settle — and the offer may come with a release that waives all future claims, including any cancer claim that develops later. The counter is simple: never sign a release without understanding what you are giving up, and never accept a settlement before the full scope of the medical monitoring need and the cancer risk has been evaluated by a qualified expert. The insurance claim process is designed to close files efficiently — your goal is to be compensated fairly, not efficiently.
Play 5: “We followed all regulations at the time.” AFFF manufacturers may argue that they complied with all applicable environmental and product-safety regulations in the years the foam was sold, and that they cannot be held liable for failing to warn about risks the government had not yet regulated. The counter is that the duty to warn is not limited to regulatory compliance — a manufacturer has an independent duty to warn of known or reasonably foreseeable dangers, and the evidence of internal toxicological research shows the dangers were known long before regulation caught up. Compliance with a regulatory floor is not a defense to failing to warn about a danger the company itself studied and documented.
Your First Steps: A Roadmap for Preserving Your Claim
If you are a firefighter who used AFFF, a resident who lived near a military base or airport, or a family member of someone diagnosed with a PFAS-associated cancer, here is what you should do — and what you should not do.
Do get a blood serum PFAS test if you have not already. This is the single most important piece of individual evidence. The test measures the concentration of PFAS compounds in your blood and establishes your internal dose. The half-lives are measured in years, but levels decline over time — so the sooner the test is done, the more accurately it captures the exposure. Keep the results. They are the starting point of your case.
Do document your exposure history. Write down every facility where you worked, trained, or lived near AFFF use. For firefighters: every fire-training academy, every military installation, every airport, every industrial facility where you sprayed or were exposed to AFFF. Include dates, the type of training or incident, the frequency (weekly, monthly, annually), and any PPE you were issued. For community residents: every address you lived at, the dates of residence, your water source (municipal or private well), and any information you have about contamination testing in your area. This timeline is the exposure reconstruction specialist’s raw material.
Do gather your medical records. If you have been diagnosed with kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, pregnancy-induced hypertension, or elevated cholesterol — the conditions the C8 Science Panel linked to PFOA — assemble your diagnosis records, treatment history, pathology reports, and imaging. The connection between your diagnosis and your exposure is built from the medical record, and the earlier it is assembled, the stronger the case.
Do not sign anything from an insurance company, a manufacturer, or a former employer without speaking to a lawyer. A release is forever. A quick check today can waive your right to pursue a cancer claim that develops tomorrow. The documents the defense will ask you to sign are designed to close your file, not to protect your future.
Do not give a recorded statement. The “just tell us what happened” call is engineered to get you to say things that will be quoted against you later — particularly about your exposure history, your medical history, and when you first learned of the PFAS connection. You have no obligation to provide a recorded statement to the other side’s insurance company. Everything you say will be transcribed and scrutinized for inconsistencies that the defense can exploit at deposition or trial.
Do not post about your case on social media. The defense monitors social media. A post about feeling “fine” or going on a hike can be used to argue your injuries are not as severe as you claim. A post about your cancer diagnosis can be taken out of context. The safest approach is to say nothing about your case, your health, or your exposure history on any platform until your case is resolved.
Do call us. The consultation is free. The call is confidential. And the day you call is the day the evidence-preservation clock starts working for you instead of against you. We can be reached at 1-888-ATTY-911, 24 hours a day, 7 days a week — not an answering service, live staff.
Why Attorney911: The Trial Team That Knows This Fight
We are Attorney911 — The Manginello Law Firm, PLLC. We have been in practice since July 18, 2001 — more than 24 years. Our managing partner, Ralph P. Manginello, has been licensed in Texas since November 6, 1998 — 27+ years — and is admitted to the U.S. District Court for the Southern District of Texas, including its Bankruptcy Court. He was a journalist before he was a lawyer, which means he learned early that the truth is found in documents, in timelines, and in the gap between what a company said publicly and what it knew internally. That skill is the backbone of toxic tort litigation — these cases are won on the manufacturer’s own internal records, the studies they conducted and the warnings they did not give.
Lupe Peña is our associate attorney, licensed in Texas since 2012, and also admitted to the U.S. District Court for the Southern District of Texas. Before he joined our firm, Lupe spent years inside a national insurance-defense firm — the rooms where adjusters and their software decided how to deny, delay, and devalue claims exactly like yours. He knows how the other side values a case, how they set reserves in the first 48 hours, how they select IME doctors, and how they engineer recorded statements. Now he uses that knowledge for injured clients. Lupe is fluent in Spanish and conducts full client consultations in Spanish without an interpreter — hablamos Español.
We work on contingency. That means we do not get paid unless we win your case. The fee is 33.33% before trial and 40% if the case goes to trial. The consultation is free — and it is a real consultation, not a sales pitch. We will tell you honestly whether we believe you have a case, what the strengths and weaknesses are, and whether we are the right firm for you. If we are not the right fit, we will tell you. Our aggregate recoveries exceed $50 million — a firm marketing figure — and we have recovered millions in trucking wrongful-death cases, $5 million-plus in brain-injury settlements, $3.8 million-plus in amputation cases. Past results depend on the facts of each case and do not guarantee future outcomes.
Frequently Asked Questions
I used AFFF firefighting foam for years and now have kidney cancer. Do I have a case?
You may. Kidney cancer is one of the two cancers with the strongest epidemiological association with PFAS exposure — the C8 Science Panel found a “probable link” between PFOA and kidney cancer, and the International Agency for Research on Cancer classified PFOA as Group 1, carcinogenic to humans. If you have a documented history of AFFF exposure (firefighter training, military crash-rescue, airport fire-suppression) and a kidney cancer diagnosis, the foundation of a claim may exist. The strength of the case depends on the clarity of your exposure history, your blood serum PFAS levels, and the ability to identify the specific manufacturer of the foam you used. We evaluate these cases individually — call us for a free consultation.
I live near a military base and have been diagnosed with testicular cancer. Can I sue?
You may have a claim against the AFFF manufacturers whose product contaminated the groundwater near the base, and potentially against the facility for failing to contain or warn of the contamination. Testicular cancer is the other cancer with a “probable link” finding from the C8 Science Panel. The community exposure pathway requires proof that your drinking water was contaminated — which may come from the state’s new testing mandate, utility records, or DOD environmental reports — and that your blood serum PFAS levels are elevated above background. If you lived near a Florida military installation and consumed local water for a significant period before your diagnosis, call us to discuss your situation.
How long do I have to file a PFAS lawsuit in Florida?
Florida’s statute of limitations for personal injury is generally four years, but in toxic tort cases involving latent diseases, the clock typically starts on the date you discovered — or by reasonable diligence should have discovered — both your injury and its causal connection to PFAS exposure. This means the four years may start from the date of your cancer diagnosis, or from when you first learned that PFAS exposure could have caused your cancer, not from the date you were exposed to the foam decades ago. However, this is a state-specific legal question that must be confirmed with an attorney, and some states impose an outer deadline (a statute of repose) that the discovery rule may not defeat. Do not assume you have plenty of time — confirm the deadline for your specific situation.
What if I have elevated PFAS levels but no cancer diagnosis?
You may still have a compensable claim for medical monitoring. Medical monitoring is a recognized cause of action that allows plaintiffs with documented elevated PFAS levels — but no current disease — to recover the cost of ongoing medical surveillance: serial blood testing, imaging, cancer-screening protocols, and the psychological burden of living with elevated cancer risk. This is not a consolation prize. It is a real injury with a real cost structure — typically valued at $50,000 to $150,000 or more depending on the surveillance protocol. If you have elevated blood-PFAS levels from occupational or community exposure, medical monitoring may be available to you.
I am a firefighter. Will my workers’ compensation cover my PFAS-related cancer?
Workers’ compensation may provide some benefits, but it is typically a no-fault, capped system that does not compensate for pain and suffering, full lost earning capacity, or the full lifetime cost of cancer care. More importantly, workers’ comp is generally the exclusive remedy against your direct employer — meaning you usually cannot sue your fire department or the military in tort. But the workers’-comp bar does not protect the chemical manufacturers who made the foam. The toxic tort claim against 3M, DuPont, Chemours, Tyco, and the other AFFF manufacturers is a separate, third-party action that is not barred by workers’ comp — and it is the claim that can provide the full measure of damages, including pain and suffering and punitive damages.
How do you prove that PFAS caused my specific cancer?
Proving specific causation in a toxic tort case requires expert testimony from multiple disciplines. A toxicologist board-certified in environmental medicine establishes general causation — that PFAS can cause the type of cancer you have, based on the epidemiological literature, the C8 Science Panel findings, and the IARC classification. An exposure reconstruction specialist estimates your specific dose — how much PFAS you absorbed, based on your employment/training records, the AFFF formulations used at your facility, the duration and frequency of exposure, and your blood serum levels. An oncologist connects your specific diagnosis to the exposure, ruling out alternative causes and testifying to a reasonable degree of medical certainty that the PFAS exposure caused or contributed to your cancer. This is not guesswork — it is a structured, evidence-based process that we build in every toxic tort case.
What is the AFFF multidistrict litigation, and should I join it?
The AFFF multidistrict litigation — MDL No. 2873, In re: Aqueous Film-Forming Foams Products Liability Litigation — is consolidated in the U.S. District Court for the District of South Carolina before Judge Richard M. Gergel. As of mid-2026, more than 15,000 actions were pending. The MDL centralizes pretrial proceedings — shared discovery, common expert witnesses, coordinated motions practice — so that each plaintiff does not have to individually litigate the same foundational questions about what the manufacturers knew and when. But joining the MDL does not merge your case into one big pot. You retain your individual case, your individual damages, and your individual right to trial. The MDL makes the shared groundwork faster and stronger; your individual case still stands on its own facts.
Are the 3M and DuPont settlements for water contamination available to individuals with cancer?
No — and this is a critical distinction. The 3M settlement (approximately $10.3 billion in present value over 13 years) and the DuPont/Chemours/Corteva settlement (approximately $1.185 billion) resolve claims by public water providers for PFAS remediation. That money is for cities and utilities to clean up contaminated water systems. It is not compensation for individuals who drank the water and got sick, and it is not compensation for firefighters who absorbed PFAS through their skin and lungs. The personal-injury cases — the cancer claims, the medical-monitoring claims — are a separate track that is still being litigated. If you have a PFAS-related disease, the water-provider settlements do not cover you. Your claim is your own, and it must be pursued individually.
How much does it cost to hire Attorney911 for a PFAS case?
Nothing up front. We work on contingency — 33.33% before trial, 40% if the case goes to trial. We do not get paid unless we win your case. The consultation is free, and it is confidential. You can reach us at 1-888-ATTY-911, 24 hours a day, 7 days a week. We have live staff — not an answering service — and we speak Spanish. Hablamos Español.
My family member died of kidney cancer after years of firefighting. Can we still file a claim?
You may be able to file a wrongful death claim. Florida allows wrongful death claims when a death is caused by the wrongful act, negligence, or breach of warranty of another — and a products-liability claim against an AFFF manufacturer whose defective product caused or contributed to the cancer falls within that framework. Florida also allows survival claims for damages the decedent accrued before death — medical expenses, lost wages, pain and suffering. The statute of limitations for wrongful death in Florida is generally two years from the date of death, which is shorter than the four-year personal-injury period — so if you have lost a family member to a PFAS-associated cancer, time is of the essence. Call us to discuss your family’s situation and the deadlines that apply.
If you have been exposed to AFFF firefighting foam — as a firefighter, a military service member, an airport worker, or a resident near a facility that used it — and you have been diagnosed with kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, or another PFAS-associated condition, the law is catching up to what happened to you. Florida’s new ban and water-testing mandate are the state’s recognition that these chemicals are dangerous and that the people who were exposed deserve to know. The legal system can hold the manufacturers accountable — but only if you act before the evidence disappears and the deadline passes.
Call us. 1-888-ATTY-911. Free consultation. No fee unless we win. Hablamos Español. 24 hours a day, 7 days a week. The day you call is the day the clock starts working for you.